Jesús Santos Selected Research

Jesús Santos Research Topics

Disease

9	Infections 01/2022 - 03/2005
7	Acquired Immunodeficiency Syndrome (AIDS) 03/2019 - 02/2007
5	HIV Infections (HIV Infection) 02/2019 - 09/2004
4	Fibrosis (Cirrhosis) 01/2022 - 11/2013
3	Coinfection 07/2009 - 01/2006
2	Chronic Hepatitis C 01/2021 - 05/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2015 - 07/2010
2	Neoplasms (Cancer) 10/2014 - 02/2007
2	Insulin Resistance 01/2012 - 01/2006
2	Jaundice (Icterus) 07/2009 - 12/2008
2	Hepatitis C 07/2009 - 11/2006
2	Hypercholesterolemia 07/2004 - 08/2002
2	Hypertriglyceridemia 07/2004 - 10/2002
1	COVID-19 01/2021
1	Adenoma (Adenomas) 10/2019
1	Gilbert Disease 07/2015
1	Virus Diseases (Viral Diseases) 05/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2015
1	Inflammation (Inflammations) 01/2014
1	Hyperlipidemias (Hyperlipidemia) 09/2013
1	Human Influenza (Influenza) 12/2012
1	Bacterial Infections (Bacterial Infection) 12/2012
1	Abdominal Obesity 07/2010
1	Obesity 07/2010
1	Pneumothorax 08/2009
1	Hepatitis B 07/2009
1	Hepatitis 07/2009
1	Viremia 10/2007
1	Syphilis 03/2007
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2007
1	Purine Nucleoside Phosphorylase Deficiency 03/2005
1	Lipodystrophy 03/2005
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2005
1	Anemia 03/2005
1	Dyslipidemias (Dyslipidemia) 07/2004
1	Diabetes Mellitus 04/2003
1	Pancreatitis 01/2002

Drug/Important Bio-Agent (IBA)

4	Atazanavir Sulfate (Reyataz)FDA Link 02/2016 - 07/2009
4	Ritonavir (Norvir)FDA Link 02/2016 - 11/2006
4	Lamivudine (Epivir)FDA Link 07/2015 - 10/2007
3	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2007
3	Pharmaceutical PreparationsIBA 12/2008 - 03/2005
3	Didanosine (Videx)FDA LinkGeneric 10/2008 - 03/2005
2	Protease Inhibitors (Protease Inhibitor)IBA 02/2016 - 01/2012
2	Reverse Transcriptase InhibitorsIBA 07/2015 - 07/2004
2	Dihydrotachysterol (AT 10)IBA 05/2015 - 07/2010
2	efavirenz (Sustiva)FDA Link 10/2008 - 10/2007
2	Zidovudine (Retrovir)FDA LinkGeneric 10/2008 - 03/2005
2	Stavudine (Zerit)FDA LinkGeneric 03/2005 - 07/2004
1	Hepatitis C AntibodiesIBA 01/2022
1	glecaprevir and pibrentasvirIBA 01/2021
1	voxilaprevirIBA 01/2021
1	SofosbuvirIBA 01/2021
1	velpatasvirIBA 01/2021
1	Ribavirin (Virazole)FDA LinkGeneric 01/2021
1	Darunavir (Prezista)FDA Link 02/2019
1	Rilpivirine (TMC-278)IBA 02/2019
1	Surface Antigens (Surface Antigen)IBA 07/2015
1	C-Reactive ProteinIBA 05/2015
1	Ferritins (Ferritin)IBA 05/2015
1	telaprevirIBA 11/2013
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 11/2013
1	VaccinesIBA 12/2012
1	LipidsIBA 01/2012
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2011
1	oxidized low density lipoproteinIBA 07/2010
1	EnzymesIBA 07/2009
1	BilirubinIBA 12/2008
1	Enfuvirtide (Fuzeon)FDA Link 02/2007
1	Lopinavir FDA Link 11/2006
1	Indinavir (Crixivan)FDA Link 01/2006
1	Adenosine (Adenocard)FDA LinkGeneric 03/2005
1	NucleosidesIBA 07/2004
1	Tenofovir (Viread)FDA Link 07/2004
1	Fenofibrate (CiL)FDA LinkGeneric 10/2002
1	Atorvastatin (Lipitor)FDA Link 08/2002
1	Triglycerides (Triacylglycerol)IBA 01/2002

Therapy/Procedure

23	Therapeutics 01/2022 - 08/2002
8	Highly Active Antiretroviral Therapy (HAART) 07/2015 - 01/2002
2	Art Therapy 05/2018 - 01/2014
1	Retreatment 01/2021
1	Segmental Mastectomy (Lumpectomy) 10/2019
1	Length of Stay 12/2012
1	Drug Therapy (Chemotherapy) 02/2007